机构：[1]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, (Guangzhou Medical University), Guangzhou 510120, China[2]Department of Respiration, The First Hospital of Yulin, Yulin 719000, China[3]Department of Emergency, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, China广东省中医院[4]Department of Respiration, First People’s Hospital of Yunnan Province, Yunnan 650032, China内科片呼吸与危重症医学科云南省第一人民医院[5]Department of Faculty of Chinese Medicine, Macau University of Science and Technology, Macau 519020, China
The direct replication of influenza virus is not the only cause of harm to human health; influenza infection leading to a hyper-inflammatory immune response can also result in serious conditions. So, the treatment strategy for influenza needs to keep balance between antivirus and anti-inflammation. Herein, we review the treatment strategies of anti-influenza drugs and traditional Chinese medicines.
基金：
National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81703788, U1201227, 81761128014, 81490534]; Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2015DFM30010]; Administration of Traditional Chinese Medicine of Guangdong Province, China [20174005]; Science Research Project of the Guangdong Province [2016A050503047]; Municipal Science and Technology Bureau Foundation of Guangzhou [2014Y2-00031]; Academician Zhong Nanshan workstation [2015IC001]
第一作者机构：[1]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, (Guangzhou Medical University), Guangzhou 510120, China
共同第一作者：
通讯作者：
通讯机构：[1]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, (Guangzhou Medical University), Guangzhou 510120, China[4]Department of Respiration, First People’s Hospital of Yunnan Province, Yunnan 650032, China[5]Department of Faculty of Chinese Medicine, Macau University of Science and Technology, Macau 519020, China[*1]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Hospital of Guangzhou Medical University, No. 151, Rd. Yanjiang, Guangzhou 510000, China[*2]Department of Respiration, First People’s Hospital of Yunnan Province, No. 157, Jinbi Road, Kunming 650032, China.
推荐引用方式(GB/T 7714)：
Li Zhengtu,Li Li,Zhao Shuai,et al.Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies[J].JOURNAL OF THORACIC DISEASE.2018,10:S2248-S2259.doi:10.21037/jtd.2018.03.169.
APA：
Li, Zhengtu,Li, Li,Zhao, Shuai,Li, Jing,Zhou, Hongxia...&Yuan, Bing.(2018).Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies.JOURNAL OF THORACIC DISEASE,10,
MLA：
Li, Zhengtu,et al."Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies".JOURNAL OF THORACIC DISEASE 10.(2018):S2248-S2259
